TRT dosing and frequency claims from Attia podcast, fact-checked

What's this video probably claiming?

Based on the caption referencing EP 274 of The Peter Attia Drive podcast, this clip almost certainly covers testosterone replacement therapy dosing protocols, injection frequency decisions (weekly vs. twice-weekly vs. daily subcutaneous), and the reasoning behind splitting doses to manage estradiol conversion and symptom stability. Attia is known for advocating individualized protocols, often discussing testosterone cypionate or enanthate in the 100-200mg per week range, with a strong preference for frequent dosing to flatten serum peaks and troughs. The clip likely also touches on hematocrit monitoring, SHBG levels as a guide for injection timing, and possibly the trade-offs between intramuscular and subcutaneous administration. More Plates More Dates, the creator behind this clip, consistently packages clinical content for a performance and optimization audience, which means the framing probably leans toward the higher end of physiologic replacement rather than strict hypogonadism treatment.

What does the science actually show?

The pharmacokinetics of testosterone cypionate and enanthate are well-documented. Both esters have a half-life of roughly 7-8 days (Bhasin et al., 2010, New England Journal of Medicine), meaning weekly injections produce meaningful peak-to-trough variation, while twice-weekly or every-other-day dosing significantly attenuates those swings. A 2021 study in the Journal of Clinical Endocrinology and Metabolism (Ramasamy et al.) confirmed that subcutaneous testosterone produces more stable serum concentrations than intramuscular in many patients at equivalent doses. Regarding estradiol management, aromatization is dose-dependent and highly individual. SHBG is a legitimate variable: men with lower SHBG clear free testosterone faster, which does support more frequent dosing logic. Hematocrit elevation above 54% is a documented risk at higher doses (Bachman et al., 2010, JCEM), making monitoring non-negotiable. None of this is fringe science. The disagreement is in application, not fundamentals.

Where does the social media noise diverge from clinical reality?

The problem is not usually what Attia says; he cites data carefully. The problem is the clip format. A 60-90 second TikTok excerpt strips context. Viewers absorb dose ranges and injection frequencies without hearing the qualifiers: these protocols assume baseline labs, physician oversight, and ongoing monitoring. More Plates More Dates has a large audience of younger men interested in optimization, not just diagnosed hypogonadism, and protocol discussions in that context can read as a permission slip. There is also a persistent myth on TikTok that splitting doses solves all estradiol issues and eliminates the need for an aromatase inhibitor. The evidence does not support that universally. Morgentaler et al. (2015, Mayo Clinic Proceedings) found estradiol management requirements vary enormously between individuals. No single dosing schedule is universally superior, and routine AI use without symptoms or confirmed high estradiol is not supported by clinical guidelines.

What should you actually know?

TRT dosing is not a protocol you optimize from a podcast clip. The Endocrine Society's 2018 clinical practice guidelines recommend targeting mid-normal physiologic testosterone ranges (400-700 ng/dL) with the lowest effective dose, not chasing peak numbers. Injection frequency should be guided by your SHBG, your symptom pattern, and your labs, not by what works for a podcaster or their guest. Hematocrit must be checked at baseline and at 3 months, full stop. Cardiovascular risk in TRT has been debated extensively; the TRAVERSE trial (Lincoff et al., 2023, New England Journal of Medicine) found no significant increase in major cardiovascular events compared to placebo in middle-aged men with hypogonadism, which is reassuring but not a blanket clearance. If you are on a regulated telehealth platform, your dosing decisions should come from your prescribing clinician reviewing your actual labs, not from a clipped Attia quote going viral.